The European Union will provisionally apply its trade deal with the Mercosur group of South American countries, overriding concern from some lawmakers who have sent the deal for a test at the bloc’s top court. Ursula von der Leyen , who leads the bloc’s executive arm as European Commission president, justified the move, saying the deal “gives Europe a strategic first mover advantage in a world of ...
The European Union will provisionally apply its trade deal with the Mercosur group of South American countries, overriding concern from some lawmakers who have sent the deal for a test at the bloc’s top court. Ursula von der Leyen , who leads the bloc’s executive arm as European Commission president, justified the move, saying the deal “gives Europe a strategic first mover advantage in a world of sharp competition and short horizons.” “Provisional application is, by its nature, provisional,” von der Leyen added. “The agreement can only be fully concluded once the European Parliament has given its consent.” The announcement comes as Argentina and Uruguay ratified the deal, a move that was hailed by European Council President Antonio Costa . Brazil and Paraguay are the other two members of the Mercosur group which signed the deal with the EU. The EU and Mercosur clinched one of the world’s largest free-trade agreements in January after 25 years of negotiations. The pact will create an integrated market of 780 million consumers and strengthen Europe’s foothold in a resource-rich region that’s increasingly contested by the US and China . Read More: EU Inks South America Trade Deal After 25 Years of Negotiations The deal has faced fierce opposition in Europe from countries with significant farming industries. French President Emmanuel Macron was among those who apposed the deal, though a majority of EU countries backed it, paving the way for its ratification. The deal still faces a hurdle at the EU’s top court, after lawmakers in the bloc’s parliament voted to submit it for a judicial review.
The amended banking law would extend regulatory power beyond lenders to the shadowy shareholders, third-party enablers and wayward employees. China is proposing the most significant overhaul of banking law in over two decades with a sweeping reform designed to better control risks simmering inside its 480 trillion yuan ($69 trillion) banking system. The proposed changes would give regulators a pow...
The amended banking law would extend regulatory power beyond lenders to the shadowy shareholders, third-party enablers and wayward employees. China is proposing the most significant overhaul of banking law in over two decades with a sweeping reform designed to better control risks simmering inside its 480 trillion yuan ($69 trillion) banking system. The proposed changes would give regulators a powerful new arsenal to police not just banks, but the entire banking ecosystem, including secretive shareholders, wayward employees and complicit auditors.
Construction laborers work on a high rise building in Kolkata on July 23, 2024. Dibyangshu Sarkar | Afp | Getty Images India's economy grew at a faster pace than expected of 7.8% in the quarter ending December. A Reuters poll of economists had pegged the October-December gross domestic product to grow at 7.2%. The latest print comes after the government overhauled the framework for calculating eco...
Construction laborers work on a high rise building in Kolkata on July 23, 2024. Dibyangshu Sarkar | Afp | Getty Images India's economy grew at a faster pace than expected of 7.8% in the quarter ending December. A Reuters poll of economists had pegged the October-December gross domestic product to grow at 7.2%. The latest print comes after the government overhauled the framework for calculating economic output to improve accuracy. In the previous quarter, India's GDP growth rate was 8.2%, which has been revised to 8.4% under the new series. The GDP growth estimate for the financial year 2026 has also been raised to 7.6% from 7.4% earlier . In January, India's Ministry of Statistics & Programme Implementation (MoSPI) introduced changes to the GDP series, inflation and industrial production data to strengthen data quality, credibility and policy relevance, it said in a statement. As part of the changes to the framework, the world's fastest-growing economy will shift the gross domestic product base year to financial year 2023 from 2012. In a report last year, the International Monetary Fund had raised concerns over the accuracy of the Indian government's economic data and assigned it a "C grade" rating, its second-lowest rank. watch now VIDEO 5:00 05:00 India's GDP overhaul: A better collection of data better than misreading economy Inside India The government data has limitations, such as the use of "an outdated base year (2011/12)" and the use of wholesale price indices and single deflation for calculating inflation, all of which can distort real economic measures, the IMF said in its report. "The new GDP series will largely address the concerns of the IMF, and as a result, we expect that their assessment and rating of India's national accounts data will change," Saurabh Garg, secretary at MoSPI, said in an interview with local media on Thursday. Domestic consumption, tariffs During the December quarter, the Indian economy saw a selective uptick in domestic consumptio...
DesignRage/iStock via Getty Images By Carsten Brzeski , Global Head of Macro German unemployment dropped by 14,700 in February, the best February performance of the labour market since 2022. At the same time, however, the fact that the absolute number of those unemployed remains
DesignRage/iStock via Getty Images By Carsten Brzeski , Global Head of Macro German unemployment dropped by 14,700 in February, the best February performance of the labour market since 2022. At the same time, however, the fact that the absolute number of those unemployed remains
It's been a tough start to the year for Hims & Hers Health (NYSE: HIMS) . The stock has been cut in half year to date and is down around 70% over the past year, as of this writing. That follows a strong run in 2024 when the stock skyrocketed more than 170%, while it tacked on a strong 34% gain last year. Much of the company's woes this year revolve around GLP-1 weight loss drugs. The company launc...
It's been a tough start to the year for Hims & Hers Health (NYSE: HIMS) . The stock has been cut in half year to date and is down around 70% over the past year, as of this writing. That follows a strong run in 2024 when the stock skyrocketed more than 170%, while it tacked on a strong 34% gain last year. Much of the company's woes this year revolve around GLP-1 weight loss drugs. The company launched a compounded version of the Wegovy pill, which it promptly stopped offering after FDA Commissioner Marty Makary said he would go after companies making copycat drugs and drugmaker Novo Nordisk filed a patent lawsuit against the telehealth company. Hims & Hers had been legally selling compounded versions of semaglutide, the active ingredient in the injectable version of Wegovy, when the drug was in shortage. Image source: Getty Images. Continue reading